MAR 31, 2020 9:00 AM PDT

Impact of liquid biopsy in advanced HER2+ breast cancer tumors: a follow-up study

Speaker

Abstract
DATE:  March 31, 2020
TIME:  9:00am PT, 12:00pm ET
 
HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2 (HER2). While this aggressive breast cancer is highly curable, with 10 year survival rates at an average of >70%, it is also highly prevalent – with this gene mutation being detected in 1 out of every 5 breast cancer cases. In addition to chemotherapy, there are multiple targeted therapies approved for treatment of HER2+ breast cancer. However, HER2+ breast cancer also has a high recurrence rate, increasing the chances of the cancer metastasizing.
 
In today's presentation, Dr. Allegretti will discuss his clinical research work on HER2+ metastatic breast cancer samples using liquid biopsy (LB) analysis. This study aims to determine feasibility of profiling and tracking over time the molecular behavior of advanced HER2+ breast cancer tumors during drug treatments. Analysis is conducted using two different LB techniques - next-generation sequencing (NGS) and digital PCR (dPCR). Results strongly encourage the integration of LB analysis with genomic assessment from tumor tissues. Together, these complementary techniques may be able to provide compelling evidence to uncover resistance/response mechanisms in the future, potentially yielding valuable clinical information for better cancer management strategies.
 
Learning Objectives:
  • Investigate advantages of analyzing advanced HER2+ metastatic breast cancer tumor samples with Liquid Biopsy 
  • Demonstrate the complementary nature of dPCR and NGS Liquid Biopsy analysis
  • Illustrate the advantages of combined tissue biopsy and Liquid Biopsy analyses
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 


Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
OCT 13, 2022 9:00 AM +08
OCT 13, 2022 9:00 AM +08
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
Loading Comments...
Show Resources